查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1769594

顯微外科及超顯微外科的全球市場:各終端用戶，設備，手術，各地區 - 2032年前的預測分析

Global Microsurgery & Super-Microsurgery Market Research by End User, by Equipment, by Procedure, by Region Forecast Analysis till 2032
出版日期: | 出版商: Market Research Future | 英文 148 Pages | 訂單完成後即時交付

價格

產業概要

2022 年，顯微外科和超顯微外科市場規模為 19.6154 億美元。預計到 2032 年，該市場規模將達到 37.8366 億美元，2023 年至 2032 年的複合年增長率為 6.07%。

人口老化和外科手術數量的增加是全球顯微外科和超顯微外科市場的主要驅動力。研發創新和移植手術的激增推動了對精準手術方法的需求，尤其是在骨科和重建領域。慢性疾病和與年齡相關的健康問題進一步加速了對高成功率顯微外科技術的需求。

然而，市場面臨著許多障礙，例如手術併發症，包括感染、傷口癒合延遲、神經損傷、可見疤痕、麻醉相關問題以及再次手術的需求。

積極的一面是，由於生活方式相關疾病的增加和技術的不斷進步，市場提供了巨大的機會。由於政府的批准以及先進眼科顯微鏡等新工具的開發，手術精度正在提高。隨著老年人和年輕人口中生活方式相關疾病的增多，這些技術創新可能會透過提供更安全、更有效的顯微手術選擇來推動市場成長。

產業區隔

全球顯微手術和超顯微手術市場按最終用戶（例如醫院和門診手術中心）進行細分。

依設備類型，全球顯微外科和超顯微外科市場分為手術顯微鏡、超微型縫合線、超微型鉗、顯微外科持針器、手術刀/眼科手術刀及其他。

依手術類別，全球顯微外科及超顯微外科市場細分為骨科顯微外科、眼科顯微外科、整形及重建顯微外科、耳鼻喉科顯微外科、神經科顯微外科及婦科及泌尿科顯微外科。

區域分析

全球顯微外科和超顯微外科市場持續發展，各地區呈現不同的趨勢。北美市場實現了顯著成長，主要得益於醫療技術的快速進步以及各專業領域對微創手術技術的日益青睞。

在歐洲，受醫療創新浪潮、人口老化和慢性病增加的推動，市場已顯著成熟。使用精密儀器和顯微鏡的顯微外科技術，以及高度專業化的超顯微外科技術，如今已廣泛應用於重建外科、骨科、眼科和整形外科。

在積極的研發投入推動下，亞太地區發展勢頭強勁。領先的醫療中心和大學正走在改進和開發複雜外科技術的前沿，以提高精準度和治療效果。

相較之下，中東、非洲和拉丁美洲的市場正在擴張，但仍面臨課題。這些地區正在意識到先進顯微外科技術的潛力，但由於缺乏熟練的專業人員、昂貴的醫療設備以及醫療基礎設施的缺口，進展緩慢。儘管人們對這些先進技術的興趣日益濃厚，但這些課題限制了其可近性，並阻礙了其廣泛應用。

主要參與者

奧林巴斯公司 (Olympus Corporation)、控制公司 (Kontron AG)、B.Braun SE、捷邁邦美 (Zimmer Biomet)、卡爾蔡司醫療 (Carl Zeiss Meditec)、全球外科公司 (Global Surgical Corporation)、Karl Kaps GmbH &Co.KG、美敦力 (Medtronic)、拓樸AB、史賽克 (Stryker)、BVI、強生服務公司 (Johnson &Johnson Services Inc)、Haag-Streit 集團、KLS 馬丁集團 (KLS Martin Group)、Microsurgery Instruments Inc、Peter Lazic GmbH、Alco Inc、Synovis Micro Companies Alliance Inc. 等是全球超顯微外科和主要產業的主要參與者。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 調查手法

  • 概要
  • 資料流程
  • 購買的資料庫：
  • 二手資料來源
  • 一手資料研究
  • 市場規模估算方法
  • 資料預測
  • 資料最終用戶
  • 團隊與分析師貢獻

第4章 市場動態

  • 簡介
  • 促進因素
    • 外科手術增加
    • 老化加劇人口
  • 阻礙因素
    • 不同手術的併發症與風險
  • 機遇
    • 生活方式相關疾病的增加與技術進步

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發
    • 製造
    • 流通與銷售
    • 銷售後監測
  • 波特的五力分析
  • COVID-19對全球顯微外科及超顯微外科市場帶來的影響
    • 供應鏈的影響
    • 主要加入企業的影響
    • 需求與供給的影響

第6章 全球顯微外科及超顯微外科市場(設備)

  • 概要
  • 手術用顯微鏡
  • 超級微縫合線
  • 微鉗子
  • 微爵士果凍針保持者
  • 外科用手術刀/眼科用小刀
  • 其他

第7章 全球顯微外科及超顯微外科市場(手術)

  • 概要
  • 整形外科微爵士果凍
  • 眼科微爵士果凍
  • 整形外科及重組微爵士果凍
  • 耳鼻喉科微爵士果凍
  • 神經學的微小外科手術
  • 婦產科及泌尿科微爵士果凍
  • 其他

第8章 全球顯微外科及超顯微外科市場(各終端用戶)

  • 概要
  • 醫院
  • 門診病人手術中心
  • 其他

第9章 全球顯微外科及超顯微外科市場(各地區)

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 其他地區
    • 中東
    • 南美

第10章 競爭情形

  • 簡介
  • 2022年的市場佔有率分析
  • 競爭儀表板
  • 公共播放器的股票摘要
  • 比較分析:主要加入企業的財務
  • 主要的發展與成長策略
    • 產品的銷售/產品核可

第1章 收購/投資/擴張

  • 競爭產品分析
    • 手術用顯微鏡
    • 微鉗子
    • 超級微縫合線
    • 微爵士果凍針保持者
    • 外科用手術刀/眼科用小刀

第11章 企業簡介

  • KONTRON AG
  • CARL ZEISS MEDITEC AG
  • GLOBAL SURGICAL CORPORATION
  • KARL KAPS GMBH & CO. KG
  • MEDTRONIC
  • OLYMPUS CORPORATION
  • SMITH+NEPHEW
  • ZIMMER BIOMET
  • TOPCON CORPORATION
  • STILLE AB

第1章 主要策略

  • B. BRAUN SE
  • STRYKER
  • BVI
  • JOHNSON & JOHNSON SERVICES INC
  • HAAG-STREIT GROUP
  • KLS MARTIN GROUP
  • 顯微外科 INSTRUMENTS, INC
  • PETER LAZIC GMBH
  • ALCON INC
  • SYNOVIS MICRO COMPANIES ALLIANCE, INC

第12章 資料的引用

Product Code: MRFR/HC/19909-CR

Global Microsurgery & Super-Microsurgery Market Research by End User (Hospitals, Ambulatory Surgical Centers, Others), by Equipment (Operating Microscopes, Super Micro Sutures, Micro Forceps, Microsurgery Needle Holder, Surgical Scalpel/ Ophthalmic Knives, Others), by Procedure (Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery, Others), by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast Analysis till 2032

Industry Overview

The market for microsurgery and super-microsurgery was valued at USD 1,961.54 million in 2022 and is expected to reach USD 3,783.66 million in 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.07% between 2023 and 2032.

The aging population and the rise in surgical operations are the main drivers of global microsurgery and super-microsurgery market. Innovations in research and development, along with a surge in transplant operations, have increased the demand for precise surgical methods, particularly in orthopedic and reconstructive fields. Chronic illnesses and age-related health issues further accelerate the need for high-success microsurgical techniques.

However, the market encounters barriers such as surgical complications, including infections, delayed wound healing, nerve damage, visible scarring, anesthesia-related problems, and the possible requirement for follow-up surgeries.

On the positive side, the market presents substantial opportunities due to the rise in lifestyle-related disorders and continued technological improvements. Government approvals and the development of new tools like advanced ophthalmic microscopes are enhancing procedural accuracy. As lifestyle diseases increase among both older and younger demographics, these innovations will drive market growth by offering safer, more effective microsurgical options.

Industry Segmentations

Global microsurgery and super microsurgery market is segmented by the end user, includes hospitals and ambulatory surgical centers and others.

In terms of equipment type, global microsurgery and super microsurgery market is categorized into operating microscopes, super micro sutures, micro forceps, microsurgery needle holder, surgical scalpel/ ophthalmic knives, and others.

Based on the procedure category, global microsurgery and super microsurgery market has been segmented into Orthopedic Microsurgery, Ophthalmic Microsurgery, Plastic & Reconstructive Microsurgery, ENT Microsurgery, Neurological Microsurgery, Gynecological & Urological Microsurgery.

North America, Asia Pacific, Europe, and rest of the world are the part of regional types of global market.

Regional Analysis

Global microsurgery and super-microsurgery market continues to evolve with distinct trends across regions. North America has experienced substantial growth, largely due to rapid advancements in medical technology and a growing inclination toward minimally invasive surgical techniques used in various specialties.

In Europe, the market has matured significantly, supported by a surge in medical innovations, an aging population, and a rise in chronic illnesses. Microsurgical techniques involving precision tools and microscopes, along with highly specialized super-microsurgery methods, are now widely utilized in reconstructive surgery, orthopedics, ophthalmology, and plastic surgery.

The Asia Pacific region is showing impressive momentum, spurred by active investment in research and development. Top-tier medical centers and universities are at the cutting edge of refining and developing complex surgical procedures that enhance accuracy and treatment outcomes.

In contrast, the market in the Middle East, Africa, and Latin America is expanding but still faces hurdles. Although these regions are recognizing the potential of advanced microsurgical techniques, progress is slowed by the lack of skilled professionals, expensive medical equipment, and gaps in healthcare infrastructure. These challenges limit accessibility and prevent widespread adoption, even as interest in these advanced procedures grows steadily.

Key Players

Olympus Corporation, Kontron AG, B. Braun SE, Zimmer Biomet, Carl Zeiss Meditec, Global Surgical Corporation, Karl Kaps GmbH & Co. KG, Medtronic, Smith+Nephew, Topcon Corporation, Stille AB, Stryker, BVI, Johnson & Johnson Services Inc, Haag-Streit Group, KLS Martin Group, Microsurgery Instruments Inc, Peter Lazic GmbH, Alco Inc, Synovis Micro Companies Alliance Inc. are the key companies of global microsurgery and super microsurgery industry.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
  • 3.7 DATA FORECASTING
    • 3.7.1 DATA FORECASTING TECHNIQUE
  • 3.8 DATA END USERLING
    • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.8.2 DATA END USERLING:
  • 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 GROWING NUMBER OF SURGICAL PROCEDURES
    • 4.2.2 INCREASING NUMBER OF GERIATRIC POPULATION
  • 4.3 RESTRAINTS
    • 4.3.1 COMPLICATIONS AND RISKS DUE TO THE PROCEDURE
  • 4.4 OPPORTUNITY
    • 4.4.1 INCREASING INCIDENCE OF LIFESTYLE DISORDERS AND GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON KEY PLAYERS
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY

6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT

  • 6.1 OVERVIEW
  • 6.2 OPERATING MICROSCOPES
  • 6.3 SUPER MICRO SUTURES
  • 6.4 MICRO FORCEPS
  • 6.5 MICROSURGERY NEEDLE HOLDER
  • 6.6 SURGICAL SCALPEL/ OPHTHALMIC KNIVES
  • 6.7 OTHERS

7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE

  • 7.1 OVERVIEW
  • 7.2 ORTHOPEDIC MICROSURGERY
  • 7.3 OPHTHALMIC MICROSURGERY
  • 7.4 PLASTIC & RECONSTRUCTIVE MICROSURGERY
  • 7.5 ENT MICROSURGERY
  • 7.6 NEUROLOGICAL MICROSURGERY
  • 7.7 GYNECOLOGICAL & UROLOGICAL MICROSURGERY
  • 7.8 OTHERS

8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 AMBULATORY SURGICAL CENTERS
  • 8.4 OTHERS

9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 REST OF ASIA-PACIFIC
  • 9.5 REST OF WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 SOUTH AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2022
  • 10.3 COMPETITOR DASHBOARD
  • 10.4 PUBLIC PLAYERS STOCK SUMMARY
  • 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

1 0.6.2 ACQUISITION/INVESTMENT/EXPANSION

  • 10.7 COMPETITOR PRODUCT ANALYSIS
    • 10.7.1 OPERATING MICROSCOPES
    • 10.7.2 MICRO FORCEPS
    • 10.7.3 SUPER MICRO SUTURES
    • 10.7.4 MICROSURGERY NEEDLE HOLDER
    • 10.7.5 SURGICAL SCALPEL/ OPHTHALMIC KNIVES

11 COMPANY PROFILES

  • 11.1 KONTRON AG
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 KEY STRATEGIES
  • 11.2 CARL ZEISS MEDITEC AG
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 GLOBAL SURGICAL CORPORATION
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 KEY STRATEGIES
  • 11.4 KARL KAPS GMBH & CO. KG
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 MEDTRONIC
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 OLYMPUS CORPORATION
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 SMITH+NEPHEW
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 ZIMMER BIOMET
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 TOPCON CORPORATION
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 STILLE AB
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS

1 1.10.5 KEY STRATEGIES

  • 11.11 B. BRAUN SE
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCT OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 SWOT ANALYSIS
    • 11.11.6 KEY STRATEGY
  • 11.12 STRYKER
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES
  • 11.13 BVI
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 FINANCIAL OVERVIEW
    • 11.13.3 PRODUCTS OFFERED
    • 11.13.4 KEY DEVELOPMENTS
    • 11.13.5 KEY STRATEGY
  • 11.14 JOHNSON & JOHNSON SERVICES INC
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 FINANCIAL OVERVIEW
    • 11.14.3 PRODUCTS OFFERED
    • 11.14.4 KEY DEVELOPMENTS
    • 11.14.5 SWOT ANALYSIS
    • 11.14.6 KEY STRATEGIES
  • 11.15 HAAG-STREIT GROUP
    • 11.15.1 COMPANY OVERVIEW
    • 11.15.2 FINANCIAL OVERVIEW
    • 11.15.3 PRODUCTSOFFERED
    • 11.15.4 KEY DEVELOPMENTS
    • 11.15.5 KEY STRATEGIES
  • 11.16 KLS MARTIN GROUP
    • 11.16.1 COMPANY OVERVIEW
    • 11.16.2 FINANCIAL OVERVIEW
    • 11.16.3 PRODUCT OFFERED
    • 11.16.4 KEY DEVELOPMENTS
    • 11.16.5 KEY STRATEGIES
  • 11.17 MICROSURGERY INSTRUMENTS, INC
    • 11.17.1 COMPANY OVERVIEW
    • 11.17.2 FINANCIAL OVERVIEW
    • 11.17.3 PRODUCTS OFFERED
    • 11.17.4 KEY DEVELOPMENTS
    • 11.17.5 KEY STRATEGIES
  • 11.18 PETER LAZIC GMBH
    • 11.18.1 COMPANY OVERVIEW
    • 11.18.2 FINANCIAL OVERVIEW
    • 11.18.3 PRODUCT OFFERED
    • 11.18.4 KEY DEVELOPMENTS
    • 11.18.5 KEY STRATEGIES
  • 11.19 ALCON INC
    • 11.19.1 COMPANY OVERVIEW
    • 11.19.2 FINANCIAL OVERVIEW
    • 11.19.3 PRODUCT OFFERED
    • 11.19.4 KEY DEVELOPMENTS
    • 11.19.5 KEY STRATEGIES
  • 11.20 SYNOVIS MICRO COMPANIES ALLIANCE, INC
    • 11.20.1 COMPANY OVERVIEW
    • 11.20.2 FINANCIAL OVERVIEW
    • 11.20.3 PRODUCT OFFERED
    • 11.20.4 KEY DEVELOPMENTS
    • 11.20.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

  • TABLE 1 QFD END USERLING FOR MARKET SHARE ASSESSMENT
  • TABLE 2 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR TOPERATING MICROSCOPES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SUPER MICRO SUTURES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICRO FORCEPS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR MICROSURGERY NEEDLE HOLDER, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR SURGICAL SCALPEL/ OPHTHALMIC KNIVES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ORTHOPEDIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OPHTHALMIC MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR PLASTIC & RECONSTRUCTIVE MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR ENT MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR NEUROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR GYNECOLOGICAL & UROLOGICAL MICROSURGERY, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 23 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 26 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 27 US: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 28 US: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 29 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 30 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 31 CANADA: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 32 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 33 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 34 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 35 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 36 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 37 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 38 GERMANY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 39 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 40 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 41 FRANCE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 42 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 43 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 44 UK: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 45 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 46 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 47 ITALY: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 48 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 49 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 50 SPAIN: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 51 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2019-2032 (USD MILLION)
  • TABLE 52 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2019-2032 (USD MILLION)
  • TABLE 53 REST OF EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 54 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 56 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 57 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 59 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 60 CHINA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 62 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 63 JAPAN: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 66 INDIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 68 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 69 AUSTRALIA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 71 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 72 SOUTH KOREA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 74 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75 REST OF ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 78 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 79 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 82 MIDDLE EAST: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 84 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 85 SOUTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86 PUBLIC PLAYERS STOCK SUMMARY
  • TABLE 87 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
  • TABLE 88 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 89 ACQUISITION /INVESTMENT/EXPANSION/COLLABORATION
  • TABLE 90 KONTRON AG: PRODUCTS OFFERED
  • TABLE 91 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED
  • TABLE 92 CARL ZEISS MEDITEC AG: KEY DEVELOPMENTS
  • TABLE 93 GLOBAL SURGICAL CORPORATION: PRODCUTS OFFERED
  • TABLE 94 KARL KAPS GMBH & CO. KG: PRODCUTS OFFERED
  • TABLE 95 MEDTRONIC: PRODCUTS OFFERED
  • TABLE 96 OLYMPUS CORPORATION: PRODCUTS OFFERED
  • TABLE 97 SMITH+NEPHEW: PRODCUTS OFFERED
  • TABLE 98 ZIMMER BIOMET: PRODCUTS OFFERED
  • TABLE 99 TOPCON CORPORATION: PRODCUTS OFFERED
  • TABLE 100 STILLE AB: PRODCUTS OFFERED
  • TABLE 101 STILLE AB: KEY DEVELOPMENTS
  • TABLE 102 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 103 STRYKER: PRODCUTS OFFERED
  • TABLE 104 BVI: PRODCUTS OFFERED
  • TABLE 105 BVI: KEY DEVELOPMENTS
  • TABLE 106 JOHNSON & JOHNSON SERVICES INC: PRODUCTS OFFERED
  • TABLE 107 HAAG-STREIT GROUP: PRODUCTS OFFERED
  • TABLE 108 KLS MARTIN GROUP: PRODUCTSOFFERED
  • TABLE 109 MICROSURGERY INSTRUMENTS, INC: PRODUCTS OFFERED
  • TABLE 110 PETER LAZIC GMBH: PRODUCT OFFERED
  • TABLE 111 ALCON: PRODUCT OFFERED
  • TABLE 112 SYNOVIS MICRO COMPANIES ALLIANCE, INC: PRODUCT OFFERED
  • TABLE 113 SYNOVIS MICRO COMPANIES ALLIANCE, INC: KEY DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET: STRUCTURE
  • FIGURE 2 GLOBAL MICROSURGERY AND SUPER-MICROSURGERY MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
  • FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
  • FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
  • FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 7 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, EQUIPMENT SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 8 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY EQUIPMENT, 2022 & 2032(USD MILLION)
  • FIGURE 9 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY EQUIPMENT, 2022 (%)
  • FIGURE 10 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, PROCEDURE SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 11 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY PROCEDURE, 2022 & 2032(USD MILLION)
  • FIGURE 12 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY PROCEDURE, 2022 (%)
  • FIGURE 13 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, END USER SEGMENT ATTRACTIVENESS, 2019-2032 (USD MILLION)
  • FIGURE 14 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET, BY END USER, 2022 & 2032(USD MILLION)
  • FIGURE 15 GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY END USER, 2022 (%)
  • FIGURE 16 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY REGION, 2022 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY REGION, 2022
  • FIGURE 18 NORTH AMERICA MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 19 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 20 NORTH AMERICA: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 21 EUROPE MARKET ANALYSIS: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 22 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 23 EUROPE: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 24 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 25 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 26 ASIA-PACIFIC: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 27 REST OF THE WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET, 2019-2032 (USD MILLION)
  • FIGURE 28 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2022 (% SHARE)
  • FIGURE 29 REST OF WORLD: MICROSURGERY & SUPER-MICROSURGERY MARKET SHARE, BY COUNTRY, 2021 & 2030 (USD MILLION)
  • FIGURE 30 GLOBAL MICROSURGERY & SUPER-MICROSURGERY PLAYERS: COMPETITIVE ANALSIS, 2022
  • FIGURE 31 COMPETITOR DASHBOARD: GLOBAL MICROSURGERY & SUPER-MICROSURGERY MARKET
  • FIGURE 32 COMPETITORS PRODUCT ANALYSIS: OPERATING MICROSCOPES
  • FIGURE 33 COMPETITORS PRODUCT ANALYSIS: MICRO FORCEPS
  • FIGURE 34 COMPETITORS PRODUCT ANALYSIS: SUPER MICRO SUTURES
  • FIGURE 35 COMPETITORS PRODUCT ANALYSIS: MICROSURGERY NEEDLE HOLDER
  • FIGURE 36 COMPETITORS PRODUCT ANALYSIS: SURGICAL SCALPEL/ OPHTHALMIC KNIVES
  • FIGURE 37 KONTRON AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 38 CARL ZEISS MEDITEC AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 CARL ZEISS MEDITEC AG: SWOT ANALYSIS
  • FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 42 OLYMPUS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 SMITH+NEPHEW: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 44 ZIMMER BIOMET: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 ZIMMER BIOMET: SWOT ANALYSIS
  • FIGURE 46 TOPCON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 STILLE AB: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 49 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 50 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 51 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 52 JOHNSON & JOHNSON SERVICES INC: SWOT ANALYSIS
  • FIGURE 53 ALCON INC: FINANCIAL OVERVIEW SNAPSHOT